Product
Tumoral specific genetic alterations
1 clinical trial
1 indication
Clinical trial
Use of Specific Genetic Alteration s of Tumoral Cells Identified by NGS to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor -Status: Completed, Estimated PCD: 2021-01-01